PCH
STOK icon

Polar Capital Holdings’s Stoke Therapeutics STOK Stock Holding History

Polar Capital Holdings’s Portfolio STOK Stock Details STOK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$27.3M Sell
833,716
-298,795
-26% -$9.59M 0.06% 155
2026
Q1 		$36.9M Sell
1,132,511
-136,620
-11% -$4.48M 0.13% 121
2025
Q4 		$40.3M Sell
1,269,131
-54,339
-4% -$1.63M 0.16% 112
2025
Q3 		$31.1M Buy
1,323,470
+439,824
+50% +$7.54M 0.15% 114
2025
Q2 		$10M Buy
+883,646
New +$8.39M 0.05% 192

Other funds holding STOK

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
LCM
Lynx1 Capital Management San Juan, Puerto Rico $866M AUM 231.68% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Toronto Dominion Bank
Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $86.4B AUM 59.51% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Polar Capital Holdings's STOK Position: Q2 2026 in Review

Polar Capital Holdings reduced its Stoke Therapeutics (STOK) stake by 26% in Q2 2026, selling an estimated $9.59M and leaving 833,716 shares worth $27.3M. The position accounts for 0.06% of the portfolio, ranked #155.

Polar Capital Holdings first reported a position in STOK in Q2 2025 and has held it in 5 quarters since. The position peaked at $40.3M in Q4 2025. 197 funds tracked by Wall St. Rank hold STOK as of Q2 2026.

  • Polar Capital Holdings held 833,716 shares of Stoke Therapeutics worth $27.3M as of Q2 2026.
  • Polar Capital Holdings sold 298,795 Stoke Therapeutics shares in Q2 2026, an estimated $9.59M.
  • Stoke Therapeutics made up 0.06% of Polar Capital Holdings's portfolio in Q2 2026, its #155 holding.
  • Polar Capital Holdings first reported a position in Stoke Therapeutics in Q2 2025 and has held it in 5 quarters since.
  • Polar Capital Holdings's Stoke Therapeutics position peaked at $40.3M in Q4 2025.
  • 197 funds tracked by Wall St. Rank held Stoke Therapeutics as of Q2 2026.

Based on Polar Capital Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.